one month after starting budesonide therapy , a significant decrease in the number of days with asthmatic symptomatology , mean symptom scores , use of concomitant antiasthmatic medications , and increase in the peak expiratory flow rates were observed compared with the 1 month run-in period .
C0054201
budesonide
C0004096
asthmatic